[Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].
This study was conducted to evaluate sympathetic cardiac innervation using MIBG imaging in PD. Uptake of MIBG was measured in 35 PD patients. Although normal MIBG uptake was observed in PD patients with HY stage l, PD with stage 3-5 revealed a total defect of visual MIBG imaging on heart area. Quantitative measurements of MIBG uptake assessed by the radioactivity ratio of cardiac to mediastinal tissue(H/ M) in early imaging was associated with the clinical severity of PD(control; 2.0 +/- 0.3, stage l; 2.0 +/- 0.1, stage 2; 1.6 +/- 0.4, stage 3-5; 1.3 +/- 0.1). In conclusion, homogeneous impairment of sympathetic cardiac innervation was observed in PD patients and this abnormality was associated with the clinical severity of PD, indicating that MIBG imaging of heart is useful not only for the evaluation of cardiac sympathetic impairment of PD but also for the diagnosis of PD.
Satoh
A
A
Division of Neurology, Nagasaki Kita Hospital.
Serita
T
T
Tsujihata
M
M
D019797:3-Iodobenzylguanidine; D000368:Aged; D001342:Autonomic Nervous System Diseases / Q000000981:diagnostic imaging* / Q000209:etiology; D003937:Diagnosis, Differential; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging* / Q000294:innervation; D006801:Humans; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008297:Male; D010300:Parkinson Disease / Q000150:complications / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging
D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine